aTyr Pharma, Inc.ATYRNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank46
3Y CAGR+2.0%
5Y CAGR+17.2%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+2.0%/yr
vs -20.7%/yr prior
5Y CAGR
+17.2%/yr
Recent deceleration
Acceleration
+22.7pp
Accelerating
Percentile
P46
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20250.13-6.8%
20240.14+9.6%
20230.13+3.9%
20220.12+909.6%
20210.01-79.4%
20200.06-82.2%
20190.32+6.7%
20180.30+37.6%
20170.22+86.4%
20160.12-